HealthLeaders Media December 5, 2018
John Commins

There’s a lot of talk about the potential for personalized medicine to lower drug costs.

Genetic testing has been around for a few years, and it’s being used to customize drug regimens for patients by better understanding how patients metabolize drugs. But proponents of individualized medicine are urging patience.

Konstantinos Lazaridis, MD, associate director of the Mayo Clinic’s Center for Individualized Medicine in Rochester, Minnesota, says that genetic testing is readily available and relatively inexpensive, costing between $300 and $400 per patient, although it’s not yet covered by insurance.

“It provides information about how you metabolize more than 300 medications that are commonly used in practice,” Lazaridis says. “What we have not proven is whether this reduces...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Precision Medicine, Technology
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers
Precision Diagnostics Can Save Money In Healthcare: What’s Holding Them Back?
Personalized Medicine Revolution: Coding, Documentation, and Reimbursement in the Genomic Era
Opinion: Personalized medicine: We’re not there yet

Share This Article